Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-26-065140
Filing Date
2026-05-21
Accepted
2026-05-21 16:05:34
Documents
11
Period of Report
2026-05-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2615121d1_8ka.htm   iXBRL 8-K/A 27124
  Complete submission text file 0001104659-26-065140.txt   192423

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA irwd-20260508.xsd EX-101.SCH 3032
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20260508_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20260508_pre.xml EX-101.PRE 22370
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2615121d1_8ka_htm.xml XML 3228
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34620 | Film No.: 261008352
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)